Evaluation of Moist desquamation in patients with radiotherapy for cervical cancer or radiotherapy combined with chemotherapy Lopburi Cancer Hospital
Keywords:
moist desquamation, cervical cancer patients, radiotherapy, radiotherapy along with chemotherapyAbstract
The purpose of this descriptive research was to assess the incidence of wet peeling. in cancer patients cervix receiving radiation treatment or radiotherapy combined with chemotherapy The sample group was cervical cancer patients undergoing radiation treatment or radiotherapy combined with chemotherapy Lopburi Cancer Hospital select specific The sample size was 57 people. or radiotherapy combined with chemotherapy Data were collected by evaluating the appearance of the skin in the radiotherapy area of cervical cancer patients from the time of admission until the patient had completed radiation therapy. During May - July 2021. Data were analyzed using descriptive statistics including percentage, mean, and standard deviation.The results of the study of the incidence of Moist desquamation of cervical cancer patients receiving radiotherapy Or radiotherapy combined with chemotherapy, it was found that 3.5% of all patients received skin care procedures.There are standardized guidelines and continuous skin assessments are performed 3 times a week. Most of them have received complete radiation therapy. According to the treatment plan without Moist desquamation up to 96.5% The results of this study demonstrated that adherence to standard skin care guidelines during radiotherapy was effective. Promoting behavior so that patients can take care of themselves properly and appropriately. contributes to reducing the incidence of Moist desquamation. Cause the patient to receive continuous radiotherapy and have a better quality of life.
References
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al., editors.GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer (IARC); 2012.
World Health Organization. Human Papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009; 84(15): 118-31.
Dawar M, Deeks S, Dobson S. Human papillomavirus vaccines launch a new era in cervical cancer prevention. CMAJ 2007; 177(5): 456-61.
Aobchey P. Incidence of cervical cancer in the country [Internet]. [cited 2021 Feb 24]. Available from: https://stri.cmu.ac.th/article_detail.php?id=17
Bermudez R.S., Huang K. Cervical cancer. Handbook of evidence-based radiation oncology.2nd ed. New York : Springer; 2001.
Porock D. Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework. European journal of cancer care 2002; 11(1): 33-43.
Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. Journal of the American Academy of Dermatology 2006;54(1):28-46.
Noble Adams R. Radiation-induced reactions . British Journal of Nursing 1999; 8:1134-40.
Glean E, Edwards S, Faithfull S, Meredith C, Richards C, Smith M, et al. Intervention for acute radiotherapy induced skin reactions in cancer patients: the development of a clinical guideline recommended for use by the college of radiographers. Journal of Radiotherapy in Practice 2001; 2:75-84.
Khuaycharoenpanich T, Wunnasawega A, Wamalun C, Ngeywichit S . Effectiveness of Moisturizing Barrier Cream during External Beam Radiation Therapy. Journal of Thai Association of Radiation Oncology 2016; 22(1): 55-61.
FN Bray, BJ Simmons, AH Wolfson, K Nouri. Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy. Dermatology and Therapy 2016;6:185-206.
Chan RJ, Webster J, Chung B, Marquart L, Ahmed M, Garantziotis S. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 2014; 14(53): 2-19.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Thailand's National Cancer Institute Foundation

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความทีตีพิมพ์ในวารสารโรคมะเร็งนี้ถือว่าเป็นลิขสิทธิ์ของมูลนิธิสถาบันมะเร็งแห่งชาติ และผลงานวิชาการหรือวิจัยของคณะผู้เขียน ไม่ใช่ความคิดเห็นของบรรณาธิการหรือผู้จัดทํา
